Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$133M |
| 2 |
AbbVie
ABBV
|
+$110M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$93.9M |
| 4 |
Amazon
AMZN
|
+$91.8M |
| 5 |
Otis Worldwide
OTIS
|
+$84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$226M |
| 2 |
RTN
Raytheon Company
RTN
|
+$145M |
| 3 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$51.2M |
| 4 |
Newmont
NEM
|
+$50.7M |
| 5 |
Yum! Brands
YUM
|
+$33.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.6% |
| 2 | Healthcare | 15.16% |
| 3 | Consumer Discretionary | 12.49% |
| 4 | Communication Services | 10.41% |
| 5 | Industrials | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Encore Capital Group
ECPG
$2.07B
| $2.14M | ﹤0.01% |
62,500
+11,300
| +22% | +$337K |
|
1677
Intellia Therapeutics
NTLA
$1.66B
| $2.14M | ﹤0.01% |
101,600
+36,100
| +55% | +$613K |
|
|
SAFE
1678
Safehold
SAFE
$1.09B
| $2.13M | ﹤0.01% |
35,541
+10,765
| +43% | +$542K |
|
1679
Strategy Inc
MSTR
$38.2B
| $2.13M | ﹤0.01% |
180,000
+20,000
| +13% | +$243K |
|
1680
ePlus
PLUS
$2.32B
| $2.13M | ﹤0.01% |
60,256
+7,800
| +15% | +$266K |
|
1681
Usana Health Sciences
USNA
$250M
| $2.12M | ﹤0.01% |
28,900
+3,400
| +13% | +$267K |
|
1682
Nelnet
NNI
$4.52B
| $2.12M | ﹤0.01% |
44,400
+5,800
| +15% | +$271K |
|
1683
Employers Holdings
EIG
$864M
| $2.12M | ﹤0.01% |
70,200
+8,500
| +14% | +$262K |
|
|
FARO
1684
DELISTED
Faro Technologies
FARO
| $2.11M | ﹤0.01% |
39,300
+5,500
| +16% | +$288K |
|
1685
DNOW Inc
DNOW
$3.04B
| $2.1M | ﹤0.01% |
243,800
+32,800
| +16% | +$225K |
|
|
ATRI
1686
DELISTED
Atrion Corp
ATRI
| $2.1M | ﹤0.01% |
3,302
+400
| +14% | +$262K |
|
|
EVOP
1687
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $2.1M | ﹤0.01% |
92,100
+12,100
| +15% | +$241K |
|
1688
Matador Resources
MTDR
$6.5B
| $2.1M | ﹤0.01% |
247,302
+32,400
| +15% | +$226K |
|
1689
Heartland Express
HTLD
$950M
| $2.1M | ﹤0.01% |
100,800
+13,400
| +15% | +$269K |
|
1690
Astec Industries
ASTE
$994M
| $2.1M | ﹤0.01% |
45,300
+3,800
| +9% | +$156K |
|
1691
Angi Inc
ANGI
$176M
| $2.09M | ﹤0.01% |
17,230
+2,260
| +15% | +$206K |
|
|
RAD
1692
DELISTED
Rite Aid Corporation
RAD
| $2.09M | ﹤0.01% |
122,390
+16,000
| +15% | +$216K |
|
1693
Fortuna Silver Mines
FSM
$3.1B
| $2.08M | ﹤0.01% |
412,400
+100,400
| +32% | +$363K |
|
|
SVM
1694
Silvercorp Metals
SVM
$2.68B
| $2.06M | ﹤0.01% |
387,800
+52,300
| +16% | +$220K |
|
|
VRTU
1695
DELISTED
Virtusa Corporation
VRTU
| $2.06M | ﹤0.01% |
63,400
+8,400
| +15% | +$260K |
|
1696
Innoviva
INVA
$1.5B
| $2.06M | ﹤0.01% |
147,000
+9,500
| +7% | +$129K |
|
1697
Lantheus
LNTH
$6.57B
| $2.05M | ﹤0.01% |
143,653
+67,553
| +89% | +$893K |
|
1698
First Busey Corp
BUSE
$2.58B
| $2.05M | ﹤0.01% |
110,099
+14,000
| +15% | +$242K |
|
|
PGTI
1699
DELISTED
PGT, Inc.
PGTI
| $2.05M | ﹤0.01% |
130,800
+17,500
| +15% | +$210K |
|
|
ONEM
1700
DELISTED
1Life Healthcare
ONEM
| $2.04M | ﹤0.01% |
+56,300
| New | +$1.59M |
|
Similar funds
Swiss National Bank's Q2 2020 Portfolio in Review
As of Q2 2020, Swiss National Bank held 2,599 positions worth $118B, up 26% from $94.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Swiss National Bank's Q2 2020 filing shows 119 new, 2,134 increased, 181 reduced and 161 closed positions. Its largest new stake was Otis Worldwide: 1,621,054 shares worth $92.2M. The largest sale was Allergan plc, an estimated $226M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q2 2020 buy was Otis Worldwide: 1,621,054 shares worth $92.2M.
- Swiss National Bank added most to Alibaba in Q2 2020, an estimated $133M increase.
- Swiss National Bank's biggest Q2 2020 reduction was Newmont, cutting an estimated $50.7M.
- Swiss National Bank fully exited Allergan plc in Q2 2020, selling an estimated $226M.
- Swiss National Bank's ten largest holdings make up 24% of its $118B portfolio in Q2 2020.
- Swiss National Bank opened 119 new positions and closed 161 in Q2 2020.
- Swiss National Bank's portfolio value rose 26% quarter-over-quarter to $118B.
Based on Swiss National Bank's 13F filing for Q2 2020, filed 5 Aug 2020.